← All diseases
Brain and nervous system
Multiple sclerosis (progressive)
Do you want to receive a message when there is new research on Multiple Sclerosis (Progressive)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you see one sentence explaining what was investigated — and you'll be notified as soon as new research on Multiple sclerosis (progressive) is published. View what Premium costs.
Publications and studies (1543)
- Understanding quality of life across different clinical subtypes of multiple sclerosis: a thematic analysis. (2022/07/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Reduced expression of mitochondrial fumarate hydratase in progressive multiple sclerosis contributes to impaired in vitro mesenchymal stromal cell-mediated neuroprotection. (2022/07/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial Comment: Paramagnetic Rim Lesions-An Imaging Biomarker for Chronic Active Lesions in Multiple Sclerosis May Help to Advance Research in Progressive Disease. (2022/07/01) ♡
- Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Impact of clinical outcomes and imaging measures on health-related quality of life in secondary progressive MS. (2022/07/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Multiple sclerosis in a child with neurofibromatosis type I - clinical management of a challenging case. (2022/06/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treatment of Inflammatory Bowel Disease and Pediatric Onset Multiple Sclerosis With Ocrelizumab and Ustekinumab in a JC-virus Positive Adolescent. (2022/06/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fatty acids role in multiple sclerosis as "metabokines". (2022/06/17) ♡
- PRMT1 is required for the generation of MHC-associated microglia and remyelination in the central nervous system. (2022/06/15) ♡
- The functional mechanisms of synchronizing royal jelly consumption and physical activity on rat with multiple sclerosis-like behaviors hallmarks based on bioinformatics analysis, and experimental survey. (2022/06/08) ♡
- Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting. (2022/06/03) ♡
- Nutritional status in patients with advanced-stage multiple sclerosis. (2022/06/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Possible association between PM(2.5) and neurodegenerative diseases: A systematic review. (2022/05/15) ♡
- Prenatal Stress Impairs Spinal Cord Oligodendrocyte Maturation via BDNF Signaling in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. (2022/05/01) ♡
- Visual Evoked Potentials to Monitor Myelin Cuprizone-Induced Functional Changes. (2022/04/15) ♡
- Anatomical and functional visual network patterns in progressive multiple sclerosis. (2022/04/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Combined Treatment with Bojungikgi-Tang and Riluzole Regulates Muscle Metabolism and Dysfunction in the hSOD1(G93A) Mouse Model. (2022/03/18) ♡
- Serum HGF and APN2 are associated with disability worsening in SPMS. (2022/03/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders. (2022/02/02) ♡
- Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis. (2022/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases. (2022/02/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - Commentary. (2022/02/01) ♡
- DMTs should be trialed in individuals with PPMS and SPMS with or without recent disease activity - No. (2022/02/01) ♡
- Epilepsy progression is associated with cumulative DNA methylation changes in inflammatory genes. (2022/02/01) ♡
- Tunisian version of the brief international cognitive assessment for multiple sclerosis: Validation and normative values. (2022/02/01) ♡
- The impact of lifetime coffee and tea loads on Multiple Sclerosis severity. (2022/02/01) ♡
- The aerobic capacity - fatigue relationship in persons with Multiple Sclerosis is not reproducible in a pooled analysis of two randomized controlled trials. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party. (2022/02/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. The effects of HMG-CoA reductase inhibitors on disease activity in multiple sclerosis: A systematic review and meta-analysis. (2022/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis? (2022/02/01) ♡
- Is there a correlation between dyslipidemia and cognitive impairment in patients with multiple sclerosis? (2022/02/01) ♡
- Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis. (2022/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pharmacotherapy of cerebellar and vestibular disorders. (2022/02/01) ♡
- Aerobic training improves blood-brain barrier and neuronal apoptosis in experimental autoimmune encephalomyelitis. (2022/02/01) ♡
- Women's Health in Multiple Sclerosis: A Scoping Review. (2022/01/31) ♡
- Effect of progressive muscle relaxation technique on self-esteem and self-efficacy in multiple sclerosis patients: A clinical trial study. (2022/01/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Paraneoplastic and Other Autoimmune Encephalitides: Antineuronal Antibodies, T Lymphocytes, and Questions of Pathogenesis. (2022/01/17) ♡
- Therapeutic Benefits of Short-Arm Human Centrifugation in Multiple Sclerosis-A New Approach. (2022/01/04) ♡
- Astrocyte-Derived Pleiotrophin Mitigates Late-Stage Autoimmune CNS Inflammation. (2022/01/03) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Risk factors of severe COVID-19 in people with multiple sclerosis : A systematic review and meta-analysis. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Charting a global research strategy for progressive MS-An international progressive MS Alliance proposal. (2022/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels. (2022/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique. (2022/01/01) ♡
- Discontinuation of disease modifying therapies is associated with disability progression regardless of prior stable disease and age. (2022/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Humoral immune response to COVID-19 vaccines in people with secondary progressive multiple sclerosis treated with siponimod. (2022/01/01) ♡
- Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. (2022/01/01) ♡
- Upper urinary tract function of patients with multiple sclerosis. (2022/01/01) ♡
- Tibolone restrains neuroinflammation in mouse experimental autoimmune encephalomyelitis. (2022/01/01) ♡
- Prescribing of disease modifying agents in older adults with multiple sclerosis. (2022/01/01) ♡
- COVID-19 outcomes in persons with multiple sclerosis treated with rituximab. (2022/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Multiple sclerosis by phenotype in Germany. (2022/01/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.